LakeShore Biopharma Co. L... (LSB)
2.62
0.02 (0.77%)
At close: Jan 15, 2025, 12:03 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY24 | FY23 | FY22 | FY21 |
| PE Ratio | -12.93 | -58.47 | -33.29K | -93.1 |
| PS Ratio | 9.77 | 12.38 | 36.12 | 69.49 |
| PB Ratio | 9.58 | 11.68 | 100.54 | 835.94K |
| P/FCF Ratio | -16.51 | -35.52 | -60.65 | -50.81 |
| P/OCF Ratio | -18.98 | -46.62 | -29.62K | -72.42 |
| OCF/S Ratio | -0.51 | -0.27 | -0.00 | -0.96 |
| Debt / Equity Ratio | 0.73 | 0.68 | 2.11 | 0.23 |
| Quick Ratio | 0.87 | 1.29 | -1.16K | 9.31K |
| Current Ratio | 1.13 | 1.57 | 7.20 | 10.47K |
| Asset Turnover | 0.38 | 0.40 | 2.50 | 2.81K |
| Interest Coverage | -10.05 | -4.52 | -0.2 | -4.24 |
| Return on Equity (ROE) | -0.74 | -0.2 | -0.00 | -8.98K |
| Return on Assets (ROA) | -0.29 | -0.08 | -0.00 | -2.10K |
| Return on Capital (ROIC) | -0.63 | -0.13 | -0.00 | -5.89K |
| Dividend Yield | n/a | n/a | n/a | n/a |
| Payout Ratio | n/a | n/a | n/a | n/a |
| Gross Profit Margin | 79.48% | 77.68% | 76.72% | 76.79% |
| Net Profit Margin | -75.59% | -21.17% | -0.11% | -74.64% |
| Pretax Profit Margin | -79.38% | -21% | -0.11% | -67.84% |
| Operating Profit Margin | -77.75% | -20.28% | -0.11% | -48.96% |
| FCF Margin | -59.2% | -34.85% | -59.56% | -136.76% |
| EBITDA Margin | -64.29% | -11.18% | -13.36% | -45.44% |